Annual Working Capital
-$650.00 K
+$99.00 K+13.22%
31 December 2022
Summary:
Nymox Pharmaceutical annual working capital is currently -$650.00 thousand, with the most recent change of +$99.00 thousand (+13.22%) on 31 December 2022. During the last 3 years, it has fallen by -$2.58 million (-133.71%).NYMX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
-$1.91 M
-$1.26 M-194.31%
31 March 2023
Summary:
Nymox Pharmaceutical quarterly working capital is currently -$1.91 million, with the most recent change of -$1.26 million (-194.31%) on 31 March 2023.NYMX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NYMX Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -133.7% | -222.0% |
| 5 y5 years | -109.3% | -134.4% |
NYMX Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -107.9% | -119.1% |
Nymox Pharmaceutical Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | -$1.91 M(+194.3%) |
| Dec 2022 | -$650.00 K(-13.2%) | -$650.00 K(-217.3%) |
| Sept 2022 | - | $554.00 K(-72.2%) |
| June 2022 | - | $2.00 M(-222.4%) |
| Mar 2022 | - | -$1.63 M(+117.6%) |
| Dec 2021 | -$749.00 K(-138.8%) | -$749.00 K(-147.8%) |
| Sept 2021 | - | $1.57 M(-66.5%) |
| June 2021 | - | $4.68 M(-6980.9%) |
| Mar 2021 | - | -$68.00 K(-103.5%) |
| Dec 2020 | $1.93 M(-41.4%) | $1.93 M(-48.4%) |
| Sept 2020 | - | $3.74 M(-430.4%) |
| June 2020 | - | -$1.13 M(-185.2%) |
| Mar 2020 | - | $1.33 M(-59.6%) |
| Dec 2019 | $3.29 M(-52.7%) | $3.29 M(-40.8%) |
| Sept 2019 | - | $5.55 M(-25.9%) |
| June 2019 | - | $7.49 M(-25.0%) |
| Mar 2019 | - | $9.99 M(+43.8%) |
| Dec 2018 | $6.95 M(-647.8%) | $6.95 M(+78.2%) |
| Sept 2018 | - | $3.90 M(+10.4%) |
| June 2018 | - | $3.53 M(-432.7%) |
| Mar 2018 | - | -$1.06 M(-16.3%) |
| Dec 2017 | -$1.27 M(+386.2%) | -$1.27 M(>+9900.0%) |
| Sept 2017 | - | -$9400.00(-99.2%) |
| June 2017 | - | -$1.14 M(+407.9%) |
| Mar 2017 | - | -$223.90 K(-14.2%) |
| Dec 2016 | -$261.00 K(-89.0%) | -$261.00 K(+92.1%) |
| Sept 2016 | - | -$135.90 K(-85.7%) |
| June 2016 | - | -$949.70 K(+240.5%) |
| Mar 2016 | - | -$278.90 K(-88.2%) |
| Dec 2015 | -$2.37 M(-23.2%) | -$2.37 M(+21.8%) |
| Sept 2015 | - | -$1.95 M(+149.3%) |
| June 2015 | - | -$781.30 K(-38.5%) |
| Mar 2015 | - | -$1.27 M(-58.9%) |
| Dec 2014 | -$3.09 M(-2.9%) | -$3.09 M(-12.4%) |
| Sept 2014 | - | -$3.53 M(-11.9%) |
| June 2014 | - | -$4.00 M(+5.2%) |
| Mar 2014 | - | -$3.80 M(+19.6%) |
| Dec 2013 | -$3.18 M(+64.4%) | -$3.18 M(+35.6%) |
| Sept 2013 | - | -$2.35 M(-11.6%) |
| June 2013 | - | -$2.65 M(+59.9%) |
| Mar 2013 | - | -$1.66 M(-14.2%) |
| Dec 2012 | -$1.93 M(-166.5%) | -$1.93 M(+22.9%) |
| Sept 2012 | - | -$1.57 M(+79.2%) |
| June 2012 | - | -$878.00 K(-287.9%) |
| Mar 2012 | - | $467.20 K(-83.9%) |
| Dec 2011 | $2.91 M(-64.9%) | $2.91 M(-10.7%) |
| Sept 2011 | - | $3.26 M(-24.2%) |
| June 2011 | - | $4.30 M(-36.5%) |
| Mar 2011 | - | $6.76 M(-18.2%) |
| Dec 2010 | $8.27 M | $8.27 M(-898.5%) |
| Sept 2010 | - | -$1.04 M(+19.0%) |
| June 2010 | - | -$870.80 K(+293.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | -$221.60 K(-66.8%) |
| Dec 2009 | -$668.30 K(-13.2%) | -$668.30 K(>+9900.0%) |
| Sept 2009 | - | -$3900.00(-99.1%) |
| June 2009 | - | -$450.80 K(-30.6%) |
| Mar 2009 | - | -$650.00 K(-15.6%) |
| Dec 2008 | -$770.00 K(-9.2%) | -$770.00 K(-16.4%) |
| Sept 2008 | - | -$921.10 K(-11.5%) |
| June 2008 | - | -$1.04 M(+47.7%) |
| Mar 2008 | - | -$704.30 K(-16.9%) |
| Dec 2007 | -$847.70 K(-51.2%) | -$847.70 K(+47.7%) |
| Sept 2007 | - | -$574.10 K(-381.7%) |
| June 2007 | - | $203.80 K(-122.6%) |
| Mar 2007 | - | -$902.90 K(-48.0%) |
| Dec 2006 | -$1.74 M(-20.0%) | -$1.74 M(-6.4%) |
| Sept 2006 | - | -$1.85 M(+21.7%) |
| June 2006 | - | -$1.52 M(+2.4%) |
| Mar 2006 | - | -$1.49 M(-31.4%) |
| Dec 2005 | -$2.17 M(+60.2%) | -$2.17 M(+19.5%) |
| Sept 2005 | - | -$1.82 M(+2.4%) |
| June 2005 | - | -$1.77 M(-2.5%) |
| Mar 2005 | - | -$1.82 M(+34.3%) |
| Dec 2004 | -$1.35 M(+38.7%) | -$1.35 M(+1.6%) |
| Sept 2004 | - | -$1.33 M(-15.4%) |
| June 2004 | - | -$1.58 M(+74.5%) |
| Mar 2004 | - | -$903.80 K(-7.4%) |
| Dec 2003 | -$976.50 K(+60.2%) | -$976.50 K(+124.6%) |
| Sept 2003 | - | -$434.70 K(-17.4%) |
| June 2003 | - | -$526.30 K(-706.3%) |
| Mar 2003 | - | $86.80 K(-114.2%) |
| Dec 2002 | -$609.40 K(+1746.7%) | -$609.40 K(+113.9%) |
| Sept 2002 | - | -$284.90 K(+42.0%) |
| June 2002 | - | -$200.60 K(-191.3%) |
| Mar 2002 | - | $219.60 K(-765.5%) |
| Dec 2001 | -$33.00 K(-107.8%) | -$33.00 K(-114.7%) |
| Sept 2001 | - | $223.80 K(-358.7%) |
| June 2001 | - | -$86.50 K(-115.5%) |
| Mar 2001 | - | $558.40 K(+31.2%) |
| Dec 2000 | $425.70 K(-853.5%) | $425.70 K(-50.0%) |
| Sept 2000 | - | $851.40 K(-35.1%) |
| June 2000 | - | $1.31 M(-50.3%) |
| Mar 2000 | - | $2.64 M(-4766.7%) |
| Dec 1999 | -$56.50 K(-102.3%) | -$56.50 K(-105.7%) |
| Sept 1999 | - | $999.20 K(-33.0%) |
| June 1999 | - | $1.49 M(-6.8%) |
| Mar 1999 | - | $1.60 M(-33.5%) |
| Dec 1998 | $2.41 M(+60.7%) | $2.41 M(-7.6%) |
| Sept 1998 | - | $2.61 M(-36.5%) |
| June 1998 | - | $4.10 M(+52.0%) |
| Mar 1998 | - | $2.70 M(+80.0%) |
| Dec 1997 | $1.50 M | $1.50 M(-28.6%) |
| Sept 1997 | - | $2.10 M(-34.4%) |
| June 1997 | - | $3.20 M |
FAQ
- What is Nymox Pharmaceutical annual working capital?
- What is the all time high annual working capital for Nymox Pharmaceutical?
- What is Nymox Pharmaceutical quarterly working capital?
- What is the all time high quarterly working capital for Nymox Pharmaceutical?
What is Nymox Pharmaceutical annual working capital?
The current annual working capital of NYMX is -$650.00 K
What is the all time high annual working capital for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high annual working capital is $8.27 M
What is Nymox Pharmaceutical quarterly working capital?
The current quarterly working capital of NYMX is -$1.91 M
What is the all time high quarterly working capital for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high quarterly working capital is $9.99 M